|
US4127580A
(en)
*
|
1975-02-07 |
1978-11-28 |
Parcor |
Process for the preparation of thieno-pyridine derivatives
|
|
FR2395271A1
(fr)
*
|
1977-06-21 |
1979-01-19 |
Parcor |
Procede de preparation de thieno (2,3-c) et thieno (3,2-c) pyridines
|
|
US4749692A
(en)
*
|
1977-06-22 |
1988-06-07 |
Sanofi, S.A. |
Therapeutic compositions having anti-thrombotic and anti-blood-platelet-aggregating activity
|
|
GB2038625B
(en)
*
|
1978-12-29 |
1983-01-12 |
Parcor |
Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
|
|
FR2397417A1
(fr)
*
|
1977-07-12 |
1979-02-09 |
Parcor |
Procede de preparation de derives de la thienopyridine
|
|
AT368504B
(de)
*
|
1977-10-15 |
1982-10-25 |
Boehringer Sohn Ingelheim |
Verfahren zur herstellung neuer 4-phenyl-thieno- (2,3-c)-piperidine
|
|
US4321266A
(en)
*
|
1980-10-06 |
1982-03-23 |
Sanofi |
5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-C] pyridine
|
|
FR2508453A1
(fr)
*
|
1981-06-30 |
1982-12-31 |
Sanofi Sa |
Procede de preparation de derives des (thienyl-2)- et thienyl-3)-2 ethylamines et produits ainsi obtenus
|
|
US4547514A
(en)
*
|
1983-12-05 |
1985-10-15 |
A. H. Robins Company, Incorporated |
Aryloxy-N-(aminoalkyl)-1-pyrrolidine and piperidine carboxamides and carbothioamides having antiarrhythmic activity
|
|
DE3736664A1
(de)
*
|
1987-10-29 |
1989-05-11 |
Boehringer Ingelheim Kg |
Tetrahydro-furo- und -thieno(2,3-c)pyridine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung
|
|
US5294621A
(en)
*
|
1992-10-07 |
1994-03-15 |
Ortho Pharmaceutical Corporation |
Thieno tetrahydropyridines useful as class III antiarrhythmic agents
|
|
WO2000000472A1
(en)
*
|
1998-06-30 |
2000-01-06 |
Du Pont Pharmaceuticals Company |
5-ht7 receptor antagonists
|
|
AU5154699A
(en)
*
|
1998-09-02 |
2000-03-27 |
Novo Nordisk A/S |
4,5,6,7-tetrahydro-thieno(2,3-c)pyridine derivatives
|
|
US6090797A
(en)
*
|
1998-09-02 |
2000-07-18 |
Novo Nordisk A/S |
4,5,6,7-tetrahydro-thieno(2,3-C)pyridine derivatives
|
|
US8914114B2
(en)
|
2000-05-23 |
2014-12-16 |
The Feinstein Institute For Medical Research |
Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
|
|
WO2003072135A2
(en)
*
|
2002-02-26 |
2003-09-04 |
North Shore-Long Island Jewish Research Insitute |
Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
|
|
CA2560756A1
(en)
|
2004-03-25 |
2005-10-06 |
The Feinstein Institute For Medical Research |
Methods and devices for reducing bleed time using vagus nerve stimulation
|
|
US10912712B2
(en)
|
2004-03-25 |
2021-02-09 |
The Feinstein Institutes For Medical Research |
Treatment of bleeding by non-invasive stimulation
|
|
US11207518B2
(en)
|
2004-12-27 |
2021-12-28 |
The Feinstein Institutes For Medical Research |
Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
|
|
EP2298410B1
(en)
|
2004-12-27 |
2013-10-09 |
The Feinstein Institute for Medical Research |
Treating inflammatory disorders by electrical vagus nerve stimulation
|
|
US8391970B2
(en)
|
2007-08-27 |
2013-03-05 |
The Feinstein Institute For Medical Research |
Devices and methods for inhibiting granulocyte activation by neural stimulation
|
|
US9662490B2
(en)
|
2008-03-31 |
2017-05-30 |
The Feinstein Institute For Medical Research |
Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
|
|
WO2009146030A1
(en)
|
2008-03-31 |
2009-12-03 |
The Feinstein Institute For Medical Research |
Methods and systems for reducing inflammation by neuromodulation of t-cell activity
|
|
ES2452484T3
(es)
|
2008-11-18 |
2014-04-01 |
Setpoint Medical Corporation |
Dispositivos para optimizar la colocación de electrodos para la estimulación antiinflamatoria
|
|
US8996116B2
(en)
|
2009-10-30 |
2015-03-31 |
Setpoint Medical Corporation |
Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
|
|
US9211410B2
(en)
|
2009-05-01 |
2015-12-15 |
Setpoint Medical Corporation |
Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
|
|
CN102573986B
(zh)
|
2009-06-09 |
2016-01-20 |
赛博恩特医疗器械公司 |
用于无导线刺激器的具有袋部的神经封套
|
|
WO2014169145A1
(en)
|
2013-04-10 |
2014-10-16 |
Setpoint Medical Corporation |
Closed-loop vagus nerve stimulation
|
|
US9833621B2
(en)
|
2011-09-23 |
2017-12-05 |
Setpoint Medical Corporation |
Modulation of sirtuins by vagus nerve stimulation
|
|
EP2515996B1
(en)
|
2009-12-23 |
2019-09-18 |
Setpoint Medical Corporation |
Neural stimulation devices and systems for treatment of chronic inflammation
|
|
EP2707094B1
(en)
|
2011-05-09 |
2016-02-03 |
Setpoint Medical Corporation |
Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
|
|
US12172017B2
(en)
|
2011-05-09 |
2024-12-24 |
Setpoint Medical Corporation |
Vagus nerve stimulation to treat neurodegenerative disorders
|
|
CN104364257B
(zh)
|
2012-03-23 |
2017-03-01 |
纪念斯隆-凯特琳癌症中心 |
5‑酰基‑6,7‑二氢噻吩并[3,2‑c]吡啶类化合物对胰腺及相关癌症的治疗作用
|
|
US9572983B2
(en)
|
2012-03-26 |
2017-02-21 |
Setpoint Medical Corporation |
Devices and methods for modulation of bone erosion
|
|
WO2016018701A1
(en)
*
|
2014-07-28 |
2016-02-04 |
Merck Sharp & Dohme Corp. |
FACTOR XIa INHIBITORS
|
|
US11311725B2
(en)
|
2014-10-24 |
2022-04-26 |
Setpoint Medical Corporation |
Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
|
|
WO2016126807A1
(en)
|
2015-02-03 |
2016-08-11 |
Setpoint Medical Corporation |
Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
|
|
US10596367B2
(en)
|
2016-01-13 |
2020-03-24 |
Setpoint Medical Corporation |
Systems and methods for establishing a nerve block
|
|
US11471681B2
(en)
|
2016-01-20 |
2022-10-18 |
Setpoint Medical Corporation |
Batteryless implantable microstimulators
|
|
EP3405255B1
(en)
|
2016-01-20 |
2025-12-31 |
Setpoint Medical Corporation |
IMPLANTABLE MICROSTIMULATORS AND INDUCTION CHARGING SYSTEMS
|
|
WO2017127756A1
(en)
|
2016-01-20 |
2017-07-27 |
Setpoint Medical Corporation |
Control of vagal stimulation
|
|
US10583304B2
(en)
|
2016-01-25 |
2020-03-10 |
Setpoint Medical Corporation |
Implantable neurostimulator having power control and thermal regulation and methods of use
|
|
US11173307B2
(en)
|
2017-08-14 |
2021-11-16 |
Setpoint Medical Corporation |
Vagus nerve stimulation pre-screening test
|
|
US11260229B2
(en)
|
2018-09-25 |
2022-03-01 |
The Feinstein Institutes For Medical Research |
Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
|
|
WO2020210786A1
(en)
|
2019-04-12 |
2020-10-15 |
Setpoint Medical Corporation |
Vagus nerve stimulation to treat neurodegenerative disorders
|
|
JP2023512447A
(ja)
|
2020-01-13 |
2023-03-27 |
ザ ファインスタイン インスティチューツ フォー メディカル リサーチ |
脾臓への高密度集束超音波刺激による出血及び出血性疾患の治療
|
|
KR20230012585A
(ko)
|
2020-05-21 |
2023-01-26 |
더 파인스타인 인스티튜츠 포 메디칼 리서치 |
미주 신경 자극을 위한 시스템들 및 방법들
|
|
US12444497B2
(en)
|
2021-05-17 |
2025-10-14 |
Setpoint Medical Corporation |
Neurostimulation parameter authentication and expiration system for neurostimulation
|
|
US20250229086A1
(en)
|
2022-01-20 |
2025-07-17 |
Setpoint Medical Corporation |
Treatment of inflammatory disorders
|
|
US12649059B2
(en)
|
2022-08-05 |
2026-06-09 |
The Feinstein Institutes For Medical Research |
Methods for reducing bleeding in hemophilia by vagus nerve stimulation to prime platelets
|